Global Trainer - All Genders H/F Biocodex

PROFILE

What We're Looking For:

- A background in scientific training, instructional design, or communication, preferably in the healthcare or pharmaceutical industry.
- Strong interest in AI, digital learning trends, and new technologies in education.
- Passion for women's health and therapeutic innovation.
- Excellent facilitation skills, cross-cultural sensitivity, and global mindset.

What We Offer:

- A dynamic and inclusive work environment within a globally recognized leader in healthcare.
- International exposure and the chance to work across diverse therapeutic areas
- Opportunities for professional growth and development : internal mobility is encouraged
- Ability to work in a global, multicultural environment

OTHER INFORMATION

Type of contract: permanent contract

Localization : Gentilly

Position open to people with disabilities

WHY BIOCODEX

Our four values are driving forces and bonds for all teams: we play collectively; we shape fair relations; we dare to innovate; we care for our ecosystem.

At Biocodex, we do not discriminate on the basis of gender, age, disability, nationality or sexual orientation. In fact, we welcome diversity, which we recognize as a source of strength for the company.

At Biocodex, our CSR approach is an holistic one to reconcile the « 4P's »: « People, Planet, Profit and Purpose » and we also ensure that our employees are provided with necessary and relevant tools for both their personal and professional development, while offering them competitive advantages and services.

Take up the challenge and send your application!

Biocodex est une société pharmaceutique française fondée en 1953 autour du développement et de la commercialisation de la première souche de levure probiotique au monde, Saccharomyces boulardii CNCM I-745®. Aujourd'hui Biocodex se développe autour de trois piliers : les microbiotes ; la santé de la femme ; et les maladies orphelines.

Biocodex emploie plus de 1 600 personnes et a réalisé un chiffre d'affaires net de plus de 500 M € en 2022 dont 1/3 en France et 2/3 à l'international. Le groupe Biocodex est présent dans 115 pays, dont 16 pays à travers ses propres filiales. Ses produits sont distribués dans le reste du monde par des sociétés partenaires.

Biocodex is a French pharmaceutical company founded in 1953 to develop and market the world's first probiotic yeast strain, Saccharomyces boulardii CNCM I-745®. Today, Biocodex focuses its business on three main areas: Microbiota care; Women's health; Orphan diseases.

With more than 1,600 employees, Biocodex generated net revenues of above €500 million in 2022, including 1/3 in France and 2/3 internationally. The group is present in 115 countries through wholly owned subsidiaries in 16 countries and a network of distributors worldwide.